ArticleBriefings in bioinformatics2026
Multi-task spatial distillation reveals cell-type-resolved programmed cell death landscapes in the human kidney.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney injury and chronic kidney disease progression are accompanied by spatially heterogeneous activation of programmed cell death (PCD), yet existing approaches have limited ability to jointly infer cell-type composition, death-program activity, and their spatial organization from spatial transcriptomics (ST) data. We present CoDeST (Confidence-weighted Dual-teacher Spatial Training), a multi-task spatial inference framework that predicts, for each ST spot, a 34-class kidney cell-type composition vector together with continuous activity scores for four PCD programs: apoptosis, pyroptosis, necroptosis, and ferroptosis. CoDeST uses a three-stage pseudo-to-real training strategy that combines self-supervised pretraining on real ST slices, supervised deconvolution on donor-matched pseudo-spots, and real-ST domain adaptation with teacher-student distillation, marker-based weak constraints, confidence-weighted AUCell/ssGSEA PCD supervision, and boundary-preserving spatial regularization. In donor-held-out pseudo-spot benchmarks, CoDeST shows competitive recovery of cell-type proportions compared with representative deconvolution methods. On real kidney ST data, marker-consistency analysis and a Visium HD-derived benchmark further support its ability to transfer deconvolution signals from pseudo-spots to real spatial tissue settings. Ablation and sensitivity analyses indicate that the three-stage design, confidence weighting, and spatial graph modeling contribute to stable deconvolution and PCD mapping while balancing spatial coherence with boundary contrast. CoDeST provides a kidney-focused framework for joint spatial mapping of cell composition and PCD-related transcriptional programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.